Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nolan Ritcey
Measuring Clinical Trial Transparency: An Empirical Analysis of Newly Approved Drugs and Large Pharmaceutical Companies
BMJ Open
Medicine
Related publications
Budget Impact of Newly Approved Drugs by the Sicilian Drug Formulary Committee: An Introductive Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab Into Clinical Practice
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Budget Transparency in Local Governments: An Empirical Analysis
SSRN Electronic Journal
Economic and Non-Economic Determinants of Iranian Pharmaceutical Companies’ Financial Performance: An Empirical Study
BMC Health Services Research
Health Policy
Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
Journal of Young Pharmacists
Toxicology
Pharmaceutics
Pharmacology
Style and Organizational Performance of Nigerian Companies: An Empirical Analysis
Journal of Applied Sciences
Clinical Trial Transparency Update: An Assessment of the Disclosure of Results of Company-Sponsored Trials Associated With New Medicines Approved in Europe in 2012
Current Medical Research and Opinion
Medicine
The Effect of Internal Corporate Social Responsibility on Job Satisfaction: An Empirical Study on Jordanian Pharmaceutical Companies
Journal of Business & Management (COES&RJ-JBM)
An Empirical Analysis of M a a Performance of Chinese Listed Companies